Halozyme Therapeutics Inc 2024 Sustainability Report
Company: Halozyme Therapeutics Inc
Sector: Manufacturing
Country: United States
Year: 2024
Type: Sustainability Report
Pages: 29
The report describes Board-level ESG oversight, a 346-person workforce as of December 1, 2024, and employee development including two Elevate cohorts covering 85% of people leaders. It also highlights environmental initiatives such as diverting laboratory waste from landfill and a goal to shift the entire fleet to hybrid vehicles by the end of 2027, achieving approximately 50% less emissions from that source.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.